ABCL (AbCellera Biologics) Land And Improvements: $53.41 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ABCL AbCellera Biologics Inc ABCL
58 GF Score
Price $6.47
GF Value $5.15
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is AbCellera Biologics Land And Improvements?

AbCellera Biologics ABCL -1.07% 58 Land And Improvements is $53.41 Mil as of Jun. 2026. GuruFocus rates ABCL with a GF Score™ of 58/100 and a GF Value™ of $5.15 (Modestly Overvalued). The stock has 2 warning signs investors should review.

AbCellera Biologics's land and improvements for the quarter that ended in Jun. 2026 was $53.41 Mil.

AbCellera Biologics's quarterly land and improvements stayed the same from Dec. 2025 ($53.41 Mil) to Mar. 2026 ($53.41 Mil) and stayed the same from Mar. 2026 ($53.41 Mil) to Jun. 2026 ($53.41 Mil).

AbCellera Biologics's annual land and improvements stayed the same from Dec. 2023 ($53.41 Mil) to Dec. 2024 ($53.41 Mil) and stayed the same from Dec. 2024 ($53.41 Mil) to Dec. 2025 ($53.41 Mil).

AbCellera Biologics Land And Improvements Historical Data

* Premium members only.

The historical data trend for AbCellera Biologics's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AbCellera Biologics Land And Improvements Chart

AbCellera Biologics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Land And Improvements
Get a 7-Day Free Trial 33.04 53.41 53.41 53.41 53.41

AbCellera Biologics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Land And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.41 53.41 53.41 53.41 53.41
ABCL
58GF Score
AbCellera Biologics Inc ABCL
Land And Improvements is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AbCellera Biologics Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Frequently Asked Questions Learn more about Land And Improvements →
What does a Land And Improvements of $53.41 Mil mean?
AbCellera Biologics (ABCL) has a Land And Improvements of $53.41 Mil as of Jun. 2026. Land and improvements records the total value of a company's land and improvements to it. View historical data on AbCellera Biologics and its competitors.
Is AbCellera Biologics' Land And Improvements too high?
AbCellera Biologics' current Land And Improvements is $53.41 Mil. Overall, AbCellera Biologics has a GF Score™ of 58/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AbCellera Biologics' Land And Improvements compare to ANAB and MLTX?
AbCellera Biologics' Land And Improvements of $53.41 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Land And Improvements for a Biotechnology company?
A good Land And Improvements depends on the Biotechnology industry context. However, Land And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Land And Improvements mean?
A high Land And Improvements can signal that a stock is expensive relative to its fundamentals. Land and improvements records the total value of a company's land and improvements to it. View historical data on AbCellera Biologics and its competitors. AbCellera Biologics's current Land And Improvements is $53.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AbCellera Biologics stock overvalued right now?
Based on GuruFocus' analysis, AbCellera Biologics (ABCL) is currently considered Modestly Overvalued. The stock's GF Value™ is $5.15, compared to a current price of $6.47 — trading 25.6% above its estimated fair value. The current Land And Improvements is $53.41 Mil. AbCellera Biologics' overall GF Score™ is 58/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Land And Improvements calculated?
Land And Improvements is calculated from a company's financial statements. For AbCellera Biologics (ABCL), the current Land And Improvements is $53.41 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AbCellera Biologics (ABCL) Overvalued in 2026?

Based on GuruFocus' analysis, AbCellera Biologics stock appears to be overvalued. The current stock price of $6.47 is trading 25.6% above its estimated GF Value™ of $5.15. GuruFocus considers AbCellera Biologics to be Modestly Overvalued.

Key valuation signals for ABCL:

  • Land And Improvements: $53.41 Mil
  • GF Value™: $5.15 vs. price of $6.47 (25.6% above fair value)
  • GF Score™: 58/100 with 2 warning signs

No single metric tells the full story. See the ABCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AbCellera Biologics Business Description

Other Exchanges 8QQ:Germany
Address 150 W 4th Avenue, Vancouver, BC, CAN, V5Y 1G6
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
58GF Score

Get the complete analysis for ABCL

Land And Improvements is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.47
Price
$5.15
GF Value